Systemic MIF facilitates chronic lymphocytic leukemia development independent of its cellular sourceViktoria Kohlhas on 29 de November de 2025 at 11:00
J Leukoc Biol. 2025 Nov 29:qiaf170. doi: 10.1093/jleuko/qiaf170. Online ahead of print. ABSTRACT Macrophage migration inhibitory factor (MIF) is broadly produced by various cell types, particularly immune cells, and functions as a key modulator of innate and adaptive immunity. Increasing evidence has linked MIF to the pathogenesis of both solid tumors and hematologic malignancies, including … Read more